Related references
Note: Only part of the references are listed.Antagonism of SET Using OP449 Enhances the Efficacy of Tyrosine Kinase Inhibitors and Overcomes Drug Resistance in Myeloid Leukemia
Anupriya Agarwal et al.
CLINICAL CANCER RESEARCH (2014)
Pin1 Regulates the Dynamics of c-Myc DNA Binding To Facilitate Target Gene Regulation and Oncogenesis
Amy S. Farrell et al.
MOLECULAR AND CELLULAR BIOLOGY (2013)
MYC suppresses cancer metastasis by direct transcriptional silencing of αv and β3 integrin subunits
Hong Liu et al.
NATURE CELL BIOLOGY (2012)
Subtype and pathway specific responses to anticancer compounds in breast cancer
Laura M. Heiser et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
Mechanistic insight into Myc stabilization in breast cancer involving aberrant Axin1 expression
Xiaoli Zhang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
SET oncoprotein overexpression in B-cell chronic lymphocytic leukemia and non-Hodgkin lymphoma: a predictor of aggressive disease and a new treatment target
Dale J. Christensen et al.
BLOOD (2011)
Phosphorylation Regulates c-Myc's Oncogenic Activity in the Mammary Gland
Xiaoyan Wang et al.
CANCER RESEARCH (2011)
CIP2A is over-expressed in acute myeloid leukaemia and associated with HL60 cells proliferation and differentiation
J. Wang et al.
INTERNATIONAL JOURNAL OF LABORATORY HEMATOLOGY (2011)
Targeting SET/I2PP2A oncoprotein functions as a multi-pathway strategy for cancer therapy
C. H. Switzer et al.
ONCOGENE (2011)
Identification of PP2A Complexes and Pathways Involved in Cell Transformation
Anna A. Sablina et al.
CANCER RESEARCH (2010)
Phosphorylation by Cdk2 is required for Myc to repress Ras-induced senescence in cotransformation
Per Hydbring et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
MYC regulation of a poor-prognosis metastatic cancer cell state
Anita Wolfer et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
CIP2A Is Associated with Human Breast Cancer Aggressivity
Christophe Come et al.
CLINICAL CANCER RESEARCH (2009)
The Axin1 scaffold protein promotes formation of a degradation complex for c-Myc
Hugh K. Arnold et al.
EMBO JOURNAL (2009)
MYC-Dependent Regulation and Prognostic Role of CIP2A in Gastric Cancer
Anchit Khanna et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2009)
PID: the Pathway Interaction Database
Carl F. Schaefer et al.
NUCLEIC ACIDS RESEARCH (2009)
SV40 small T antigen and PP2A phosphatase in cell transformation
Anna A. Sablina et al.
CANCER AND METASTASIS REVIEWS (2008)
A tumor suppressor role for PP2A-B56α through negative regulation of c-Myc and other key oncoproteins
Hugh K. Arnold et al.
CANCER AND METASTASIS REVIEWS (2008)
FBXW7 targets mTOR for degradation and cooperates with PTEN in tumor suppression
Jian-Hua Mao et al.
SCIENCE (2008)
Multiple pathways regulated by the tumor suppressor PP2A in transformation
Jukka Westermarck et al.
TRENDS IN MOLECULAR MEDICINE (2008)
Mutation analysis of five candidate genes in familial breast cancer
A. Marsh et al.
BREAST CANCER RESEARCH AND TREATMENT (2007)
CIP2A inhibits PP2A in human malignancies
Melissa R. Junttila et al.
CELL (2007)
Aberrant stabilization of c-Myc protein in some lymphoblastic leukemias
S. Malempati et al.
LEUKEMIA (2006)
Role of post-translational modifications in regulating c-Myc proteolysis, transcriptional activity and biological function
Stephen R. Hann
SEMINARS IN CANCER BIOLOGY (2006)
Protein phosphatase 2A regulatory subunit b56α associates with c-Myc and negatively regulates c-Myc accumulation
HK Arnold et al.
MOLECULAR AND CELLULAR BIOLOGY (2006)
The glycine 90 to aspartate alteration in the Aβ subunit of PP2A (PPP2R1B) associates with breast cancer and causes a deficit in protein function
ED Esplin et al.
GENES CHROMOSOMES & CANCER (2006)
The tumor suppressor PP2A is functionally inactivated in blast crisis CML through the inhibitory activity of the BCR/ABL-regulated SET protein
P Neviani et al.
CANCER CELL (2005)
Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles
A Subramanian et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
A signalling pathway controlling c-Myc degradation that impacts oncogenic transformation of human cells
E Yeh et al.
NATURE CELL BIOLOGY (2004)
Amplification of c-myc gene and overexpression of c-Myc protein in breast cancer and adjacent non-neoplastic tissue
P Chrzan et al.
CLINICAL BIOCHEMISTRY (2001)
C-myc amplification in breast cancer: a meta-analysis of its occurrence and prognostic relevance
SL Deming et al.
BRITISH JOURNAL OF CANCER (2000)
Multiple Ras-dependent phosphorylation pathways regulate Myc protein stability
R Sears et al.
GENES & DEVELOPMENT (2000)
Low frequency of alterations of the α (PPP2R1A) and β (PPP2R1B) isoforms of the subunit A of the serine-threonine phosphatase 2A in human neoplasms
GA Calin et al.
ONCOGENE (2000)
Share Paper
